Peptide education

Dipeptide diaminobutyroyl benzylamide diacetate

Dipeptide diaminobutyroyl benzylamide diacetate is a synthetic ingredient used in skin-conditioning cosmetics.

A controlled study reported changes in some forehead wrinkle measures with a peptide-containing formulation. Two other studies tested a combined serum without a control group. Neither establishes the effect of pure peptide alone.

UseTopical cosmetic
Human evidenceSmall formulation studies
Main limitSeveral ingredients tested

Overview

Quick answer

A study of a serum containing several ingredients cannot tell us what this ingredient does on its own. It is not botulinum toxin or snake venom.

Does it work like botulinum toxin?

The substances and routes are different. The cosmetic studies did not directly measure an equivalent effect on facial neuromuscular transmission.

What did the studies show?

A controlled comparison found differences in some forehead measurements with a peptide-containing blend. Two uncontrolled serum studies reported changes from baseline, but did not isolate the peptide's contribution.

What is known about safety?

No adverse events were reported during the two short serum studies. This does not establish long-term safety or rule out rare reactions.

Evidence

Evidence snapshot

Controlled comparison57 women, 4 weeks

The active formulation contained a peptide ingredient blend and differed from the placebo in its carriers.

Static lines50 women assessed

A single-arm study reported changes from baseline after use of the combined serum.

Dynamic lines42 completers

A second single-arm study evaluated facial expressions after use of the same serum.

Claims

Common claims vs evidence

ClaimHuman evidenceMechanistic evidenceVerdict
This ingredient alone reduces expression lines.One comparison used a peptide blend with different carriers from placebo; two other studies tested a combined serum without a control group.The cosmetic studies did not directly establish a peptide-specific effect on facial muscle activity.The ingredient's individual contribution remains uncertain.

Bottom line

Main takeaway

Ingredient basics

This is a cosmetic ingredient, not botulinum toxin or venom.

Comparing products

The finished serum and its other ingredients affect both results and tolerability.

Evidence gap

An ingredient-specific comparison with a matched vehicle would improve attribution.

Identity

What it is

The full ingredient name describes a modified synthetic substance listed for skin conditioning. Similar marketing names do not establish chemical identity.

Research

Research evidence

A controlled comparison tested a peptide-containing blend against placebo. Two other studies examined a multi-ingredient serum without a control group.

Study / evidence areaPopulationDesignProduct contextMain outcomeLimitationsWeight
Controlled formulation comparison57 women aged 50 to 65; 29 assigned the active formulation and 28 placeboRandomized, double-blind, placebo-controlled study over 4 weeksA cream containing 4% of a commercial peptide ingredient blend, compared with a placebo formulationForehead wrinkle area and length while frowning differed in favor of the active formulation; mouth-area measures did not differ significantly.The placebo replaced the glycerin-containing blend with water; follow-up was short and authors had industry affiliations.Limited controlled formulation evidence
Static wrinkle serum study50 Chinese women completed clinical assessmentsSingle-arm study with measurements over 12 weeksSerum containing the peptide, acetyl hexapeptide-8, gluconolactone, niacinamide, and laminaria extractInvestigators reported lower wrinkle scores compared with baseline.No control group or test of this ingredient alone; manufacturer-funded study.Limited uncontrolled product evidence
Dynamic wrinkle serum study42 Chinese women completed assessmentsSingle-arm study with measurements over 8 weeksThe same multi-ingredient serumInvestigators reported lower ratings of expression-related lines compared with baseline.No control group or ingredient-only arm; seven participants were lost to follow-up.Limited uncontrolled product evidence

Use context

Reported use context

The studies used specific facial formulations twice daily; their results do not apply to every product.

Study and label context

01
Controlled formulation comparisonTopical facial cream

Participants applied their assigned formulation morning and evening for 4 weeks.

The 4% concentration referred to a commercial ingredient blend, not pure peptide; this is not a recommendation.
02
The two serum studiesTopical facial serum

Participants applied the study serum morning and evening.

The studies lasted 12 and 8 weeks and tested a complete formula, not the ingredient alone; this is not a recommendation.

Cautions

Safety and unknowns

  • The serum studies reported no adverse events, but their size and duration cannot rule out uncommon or delayed reactions.
  • Effects of applying other formulations or using non-topical routes are not established by these studies.

Product quality

Product identity and quality

The full formulation can influence delivery, performance, and skin tolerability.

Ingredient identity

Check the complete ingredient name rather than assuming similar peptide names are interchangeable.

Concentration basis

The amount of an ingredient solution is not necessarily the amount of pure peptide.

Mechanism

How it is proposed to work

The ingredient is marketed for expression lines, but a claimed nerve or muscle effect is not established by the cited product studies.

01

The tested serum contained several other actives and did not isolate this ingredient's mechanism.

Details

Technical details

Dipeptide diaminobutyroyl benzylamide diacetate technical details
Ingredient name
Dipeptide diaminobutyroyl benzylamide diacetate
Evidence context
One controlled formulation study and two uncontrolled studies of a combined serum
Product classification
US classification depends on intended use and claims

Sources

References

  1. 1.

    Primary study. Facial Expression Wrinkles and Their Relaxation by a Synthetic Peptide

    doi:10.1007/s10989-020-10146-z

    Randomized, double-blind comparison of a peptide-containing blend and a placebo formulation; the formulations differed in their carriers.

  2. 2.

    PubMed Central. The effect of a serum containing acetyl hexapeptide-8, dipeptide diaminobutyroyl benzylamide diacetate and gluconolactone on skin biomarkers, wrinkles and skin texture: Ex vivo and clinical studies

    doi:10.1111/ics.70087 PMID:41668671

    Two single-arm studies of one multi-ingredient serum; the peptide's contribution was not isolated.

  3. 3.

    Health Canada. Dipeptide Diaminobutyroyl Benzylamide Diacetate

    Ingredient listing identifies the substance and its skin-conditioning function.

  4. 4.

    FDA. Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)

    US product classification depends on intended use.